Related Experiment Video
Updated: May 7, 2026

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
DRESS syndrome in a child treated for toxoplasma retinochoroiditis
Imran H Yusuf1, Prashant Sahare, G Darius Hildebrand
1Royal Berkshire Hospital NHS Foundation Trust, London Road, Reading, United Kingdom.
Insights
Severe adverse drug reactions, including the life-threatening Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome, can occur in children treated for toxoplasma retinochoroiditis. Early recognition and treatment are crucial for recovery.
Area of Science:
- Ophthalmology
- Pediatrics
- Pharmacology
Background:
- Toxoplasma retinochoroiditis requires treatment, often with a combination of sulfadiazine, pyrimethamine, folinic acid, and steroids.
- Severe adverse drug reactions, such as DRESS syndrome, are known complications.
- Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome has a significant mortality rate.
Observation:
- A pediatric case of DRESS syndrome is presented in a child receiving standard treatment for toxoplasma retinochoroiditis.
- The patient was treated with oral sulfadiazine, pyrimethamine, folinic acid, and steroids.
- The child developed symptoms indicative of DRESS syndrome.
Findings:
- Early clinical recognition of DRESS syndrome was achieved.
- Prompt and appropriate treatment was initiated.
- The child experienced a complete recovery without long-term sequelae.
Implications:
- This case highlights the importance of recognizing DRESS syndrome in children treated for toxoplasma retinochoroiditis.
- Counseling parents on potential nonspecific illness symptoms during sulfadiazine treatment is vital.
- Vigilance for severe adverse drug reactions can lead to favorable outcomes in pediatric patients.
Abstract:
Children treated for toxoplasma retinochoroiditis may experience a range of severe adverse drug responses. Drug reaction with eosinophilia and systemic symptoms syndrome is a life-threatening idiosyncratic drug reaction with a 10% mortality. We present a case of drug reaction with eosinophilia and systemic symptoms syndrome in a child on standard combination treatment with oral sulfadiazine, pyrimethamine, folinic acid, and steroids for toxoplasma retinochoroiditis. Early clinical recognition and appropriate treatment led to a complete recovery and no longterm sequelae. The parents of children during sulfadiazine treatment should be counseled on the potential significance of nonspecific illness.
More Related Videos
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
08:38Electroretinogram Recording for Infants and Children under Anesthesia to Achieve Optimal Dark Adaptation and International Standards
Published on: September 3, 2020
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Toxidromes: Clinical Features
Nephrotic Syndrome III : Nursing Management
Diabetic Retinopathy